NYSE:TPVG - Triplepoint Venture Growth BDC Stock Price, Forecast & News

Triplepoint Venture Growth BDC trades on the New York Stock Exchange (NYSE) under the ticker symbol "TPVG."

Triplepoint Venture Growth BDC announced a quarterly dividend on Wednesday, November 6th. Stockholders of record on Friday, November 29th will be paid a dividend of $0.36 per share on Monday, December 16th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 10.13%. The ex-dividend date of this dividend is Wednesday, November 27th. View Triplepoint Venture Growth BDC's Dividend History.

Triplepoint Venture Growth BDC Corp (NYSE:TPVG) announced its earnings results on Wednesday, November, 6th. The investment management company reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.42 by $0.13. The investment management company earned $15.69 million during the quarter, compared to the consensus estimate of $19.27 million. Triplepoint Venture Growth BDC had a net margin of 50.68% and a return on equity of 11.00%. View Triplepoint Venture Growth BDC's Earnings History.

Triplepoint Venture Growth BDC is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Triplepoint Venture Growth BDC.

3 equities research analysts have issued 12 month price targets for Triplepoint Venture Growth BDC's shares. Their forecasts range from $14.50 to $16.00. On average, they anticipate Triplepoint Venture Growth BDC's share price to reach $15.50 in the next year. This suggests a possible upside of 9.0% from the stock's current price. View Analyst Price Targets for Triplepoint Venture Growth BDC.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Triplepoint Venture Growth BDC in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Triplepoint Venture Growth BDC.

News articles about TPVG stock have trended somewhat positive on Sunday, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Triplepoint Venture Growth BDC earned a daily sentiment score of 1.3 on InfoTrie's scale. They also assigned media stories about the investment management company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View News Stories for Triplepoint Venture Growth BDC.

Some companies that are related to Triplepoint Venture Growth BDC include New Mountain Finance (NMFC), Pennantpark Floating Rate Capital (PFLT), Gladstone Investment (GAIN), PennantPark Investment (PNNT), Capital Southwest (CSWC), Stellus Capital Investment (SCM), Oaktree Strategic Income (OCSI), Safeguard Scientifics (SFE), Arlington Asset Investment (AI), THL Credit (TCRD), Allied Minds (ALLWF), OFS Capital (OFS), Capitala Finance (CPTA), InvestcorpCreditManagementBDCInc . (ICMB) and CM Finance (CMFN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Triplepoint Venture Growth BDC investors own include Chembio Diagnostics (CEMI), Prospect Capital (PSEC), Two Harbors Investment (TWO), New Residential Investment (NRZ), Calumet Specialty Products Partners, L.P (CLMT), Washington Prime Group (WPG), Energy Transfer LP Unit (ET), Blackrock Capital Investment (BKCC), Summit Midstream Partners (SMLP) and Viper Energy Partners (VNOM).

Triplepoint Venture Growth BDC's stock is owned by a number of of institutional and retail investors. Top institutional investors include Confluence Investment Management LLC (2.21%), Delphi Management Inc. MA (0.38%), Wiley BROS. Aintree Capital LLC (0.35%), Essex Investment Management Co. LLC (0.30%), California Public Employees Retirement System (0.16%) and First Allied Advisory Services Inc. (0.10%). Company insiders that own Triplepoint Venture Growth BDC stock include James Labe and Sajal Srivastava. View Institutional Ownership Trends for Triplepoint Venture Growth BDC.

TPVG stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Wiley BROS. Aintree Capital LLC, Delphi Management Inc. MA, Essex Investment Management Co. LLC, Advantage Investment Management LLC and Commonwealth Equity Services LLC. View Insider Buying and Selling for Triplepoint Venture Growth BDC.

TPVG stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Virtu Financial LLC, First Allied Advisory Services Inc., Steward Partners Investment Advisory LLC, Stifel Financial Corp, Envestnet Asset Management Inc., Canton Hathaway LLC and Wiley BROS. Aintree Capital LLC. Company insiders that have bought Triplepoint Venture Growth BDC stock in the last two years include James Labe and Sajal Srivastava. View Insider Buying and Selling for Triplepoint Venture Growth BDC.

Shares of TPVG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TPVG stock can currently be purchased for approximately $14.22.

Triplepoint Venture Growth BDC has a market capitalization of $354.08 million and generates $64.65 million in revenue each year. The investment management company earns $36.56 million in net income (profit) each year or $1.71 on an earnings per share basis. View Additional Information About Triplepoint Venture Growth BDC.

The official website for Triplepoint Venture Growth BDC is http://www.tpvg.com/.

Triplepoint Venture Growth BDC's mailing address is 2755 SAND HILL ROAD SUITE 150, MENLO PARK CA, 94025. The investment management company can be reached via phone at 650-854-2090 or via email at [email protected]